Archives
-
Human ClpP Activators: Findings from a 2025 Review
2026-10-07
The 2025 review by Shu and colleagues synthesizes how small-molecule activators and inhibitors are being designed to target human mitochondrial ClpP, with emphasis on structure–activity relationships, selectivity, pharmacology, and anticancer mechanisms. Its main implication is that ClpP activation may create a therapeutically useful mitochondrial stress state, although model dependence, assay heterogeneity, pharmacokinetic uncertainty, and limited clinical evidence remain important constraints.
-
Dual SMAD and Wnt Inhibition for iPSC-RGCs
2026-10-07
Chavali and colleagues reported a chemically defined, non-genetic strategy for directing induced pluripotent stem cells toward retinal ganglion cells by coordinating SMAD and canonical Wnt pathway inhibition. The resulting cultures exceeded 80% RGC purity, with Thy-1-positive enrichment approaching 95%, supporting more reproducible in vitro models of glaucoma and retinal neurodegeneration.
-
HR-LCMS/MS Reveals a New Glabrol Producer
2026-10-06
A 2026 study presents a high-resolution LC-MS/MS dereplication workflow that links bioactive plant fractions to candidate autophagy inducers. Using SH-SY5Y cells, LC3 I/II immunoblotting, chromatographic fractionation, and mass-spectrometric profiling, the authors identify Astragalus dasyanthus as a previously unreported source of glabrol-associated autophagy activity.
-
Dual SMAD/Wnt Inhibition for iPSC-RGC Differentiation
2026-10-06
Chavali and colleagues reported a chemically defined, non-genetic strategy that combines dual SMAD and canonical Wnt pathway inhibition to generate retinal ganglion cells from induced pluripotent stem cells. The study’s reported purity, enrichment, and reproducibility support iPSC-derived RGCs as a research platform for glaucoma biology, while the findings do not by themselves establish therapeutic efficacy or in vivo retinal repair.
-
MG-132 Beyond Apoptosis: A Proteostasis Lens
2026-10-05
MG-132 and Z-LLL-al are examined as interpretive tools for proteasome biology, apoptosis, and antigen-presentation research. This evidence-focused analysis connects proteostasis perturbation with findings from a T-cell-inducing COVID-19 vaccine study without overstating cross-domain conclusions.
-
Metronidazole: From Transporter Probe to Translation
2026-10-05
Metronidazole sits at the intersection of antimicrobial biology, transporter pharmacology, and microbiome research. This thought-leadership analysis examines how its reported OAT3 inhibition and established nitroimidazole identity can support translational questions—while separating product-level claims from peer-reviewed evidence and avoiding overinterpretation.
-
Multiplexed CRISPR: From Control to Translation
2026-10-04
A thought-leadership perspective on how a three-guide EGFP reference set can support rigorous thinking about multiplexed CRISPR validation, while separating mechanistic promise from evidence that is ready for translational decision-making.
-
URB597 and FAAH Signaling in Pain Research
2026-10-03
URB597, also known as KDS-4103, is a research tool used to investigate FAAH-dependent endocannabinoid signaling. This overview places its reported pharmacology alongside a 2026 mouse study of cannabidiol in inflammatory pain, emphasizing what the findings support, what they do not establish, and where translational limitations remain.
-
Multiplexed CRISPR Design: From Control to Translation
2026-10-02
Multiplexed CRISPR experiments are most valuable when they are designed as decision systems rather than simple multi-guide transfections. Using an EGFP reporter in HeLa cells as a tractable benchmark, this article connects guide-set validation, repair-outcome analysis, assay controls, and translational risk management.
-
Tofacitinib citrate: Reliable JAK Assays
2026-10-01
This scenario-driven guide shows how Tofacitinib citrate (CP-690550 citrate), SKU A4135, can support better-controlled viability, proliferation, cytokine, and inflammatory-cell experiments. It connects product handling data with concentration-aware interpretation of JAK-STAT and endothelial inflammation studies.
-
Dual Recombinase Tracing and Mouse Neo-oogenesis
2026-10-01
Xie, Zhou, and Zheng used orthogonal Cre-loxP and Dre-rox lineage tracing to test whether postnatal ovarian cells generate new oocytes in mice. Across physiological aging and busulfan-induced injury, the study detected no labeled growing oocytes or MII eggs, providing strong in vivo evidence against postnatal neo-oogenesis.
-
Asymmetric Suzuki Synthesis of an Axially Chiral Antimitotic
2026-09-30
Herrbach and co-workers reported the first application of an atropo-enantioselective Suzuki coupling to a biologically relevant antimitotic target, using chiral phosphine ligand 7a to form a nonbridged axially chiral biaryl precursor with up to 40% ee. The study provides a focused strategy for installing axial chirality before construction of the bridged biaryl framework found in rhazinilam analogues.
-
Novel Allosteric PDK4 Inhibitors in Metabolic Disease
2026-09-30
The reference study used anthraquinone-based optimization to identify compound 8c, a new allosteric pyruvate dehydrogenase kinase 4 inhibitor with nanomolar biochemical activity and preliminary in vivo efficacy. Its findings connect PDK4 inhibition with PDH activation, glucose handling, allergic inflammation, and cancer-related phenotypes while also illustrating the limitations of translating biochemical potency into therapeutic evidence.
-
Self-Assembling Peptide Nanotubes for mRNA Delivery
2026-09-29
Jung and Lim describe a structure-controlled strategy for packaging mRNA into nanotube-shaped vehicles assembled from designed peptide building blocks. The protocol links peptide synthesis and mRNA complexation with morphological, physicochemical, stability, and intracellular assays, providing a framework for evaluating filamentous carriers beyond conventional spherical nanoparticles.
-
Milk-Derived EV Uptake in Intestinal Stem Cell Models
2026-09-29
The reference study develops three porcine intestinal stem cell–based models to examine how milk-derived extracellular vesicles interact with physiologically relevant epithelium. Its central findings are that uptake depends on epithelial polarity, colon-derived stem cells show transcriptional responses to vesicles, and internalization is sensitive to endocytosis inhibition.